Latest News and Press Releases
Want to stay updated on the latest news?
-
BBOT to Participate in Upcoming September Investor Healthcare Conferences
-
BBOT Debuts as Publicly Traded Company Focused on RAS-Pathway Malignances with a Potential to Realize the Full Promise of KRAS and PI3K Inhibition